Valuation Chongqing Zhifei Biological Products Co., Ltd.
Equities
300122
CNE100000V20
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.95 CNY | -0.82% |
|
-16.05% | -10.17% |
Company Valuation: Chongqing Zhifei Biological Products Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 236,656 | 199,360 | 140,528 | 146,664 | 62,957 | 40,575 | 40,575 | - |
| Change | - | -15.76% | -29.51% | 4.37% | -57.07% | -35.55% | 0% | - |
| Enterprise Value (EV) 1 | 238,093 | 195,858 | 139,911 | 143,334 | 72,599 | 41,122 | 35,076 | 35,808 |
| Change | - | -17.74% | -28.56% | 2.45% | -49.35% | -43.36% | -14.7% | 2.09% |
| P/E ratio | 71.7x | 19.6x | 18.6x | 18.2x | 31.2x | -17.7x | 33.2x | 31.8x |
| PBR | 28.7x | 11.3x | 5.8x | 4.66x | 2.04x | 1.4x | 1.25x | 1.28x |
| PEG | - | 0x | -0.7x | 2.59x | -0.4x | 0x | -0x | 6.88x |
| Capitalization / Revenue | 15.6x | 6.51x | 3.67x | 2.77x | 2.41x | 3.82x | 2.48x | 2.91x |
| EV / Revenue | 15.7x | 6.39x | 3.66x | 2.71x | 2.78x | 3.87x | 2.14x | 2.56x |
| EV / EBITDA | 59.1x | 15.8x | 15.4x | 14.8x | 27.3x | -25.9x | 49.6x | 16.7x |
| EV / EBIT | 61.1x | 16.3x | 16x | 15.3x | 32.1x | -26.4x | 264x | 23.4x |
| EV / FCF | 89.2x | 29.8x | 261x | 17.8x | -13.6x | 3.34x | 6.54x | - |
| FCF Yield | 1.12% | 3.36% | 0.38% | 5.6% | -7.35% | 29.9% | 15.3% | - |
| Dividend per Share 2 | 0.3333 | 0.4 | 0.3333 | 0.8 | 0.2 | - | 0.1104 | 0.03 |
| Rate of return | 0.34% | 0.48% | 0.57% | 1.31% | 0.76% | - | 0.65% | 0.18% |
| EPS 2 | 1.375 | 4.249 | 3.141 | 3.362 | 0.8427 | -0.9596 | 0.5102 | 0.5338 |
| Distribution rate | 24.2% | 9.41% | 10.6% | 23.8% | 23.7% | - | 21.6% | 5.62% |
| Net sales 1 | 15,190 | 30,637 | 38,264 | 52,918 | 26,070 | 10,623 | 16,354 | 13,963 |
| EBITDA 1 | 4,027 | 12,394 | 9,079 | 9,700 | 2,656 | -1,590 | 707.4 | 2,138 |
| EBIT 1 | 3,894 | 11,986 | 8,758 | 9,373 | 2,264 | -1,560 | 132.9 | 1,532 |
| Net income 1 | 3,300 | 10,197 | 7,539 | 8,070 | 2,018 | -3,541 | 743.2 | 1,275 |
| Net Debt 1 | 1,437 | -3,502 | -616.7 | -3,330 | 9,643 | 547.4 | -5,499 | -4,767 |
| Reference price 2 | 98.61 | 83.07 | 58.55 | 61.11 | 26.30 | 16.95 | 16.95 | 16.95 |
| Nbr of stocks (in thousands) | 2,400,000 | 2,400,000 | 2,400,000 | 2,400,000 | 2,393,790 | 2,393,790 | 2,393,790 | - |
| Announcement Date | 2/21/21 | 2/8/22 | 3/20/23 | 4/22/24 | 4/21/25 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -17.66x | 3.87x | -25.86x | -.--% | 5.83B | ||
| 18.35x | 4.95x | 12.57x | 0.49% | 76.88B | ||
| 56.43x | 14.92x | 32x | -.--% | 59.21B | ||
| 22.78x | 4.14x | 12.04x | 2.58% | 57.42B | ||
| 42.04x | 6.67x | 21.36x | 0.56% | 56.2B | ||
| 16.63x | 2.75x | 8.67x | -.--% | 25.32B | ||
| 16.88x | 3.32x | 9.99x | -.--% | 20.55B | ||
| 75.69x | 9x | 81.18x | -.--% | 18.4B | ||
| 275.33x | 96.16x | 170.11x | - | 13.64B | ||
| -6.23x | 7.59x | -4.47x | -.--% | 19.46B | ||
| Average | 50.02x | 15.34x | 31.76x | 0.4% | 35.29B | |
| Weighted average by Cap. | 39.99x | 10.38x | 24.81x | 0.64% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 300122 Stock
- Valuation Chongqing Zhifei Biological Products Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















